Table 1 Characteristics of 69 male patients with ankylosing spondylitis in western Sweden
n(%) | Median (range) | Mean ± SD | |
|---|---|---|---|
Age, years | 48 (17, 78) | 49 ± 15 | |
Years since symptom onset | 20 (2, 55) | 23 ± 14 | |
Present or past iritis | 37 (54) | ||
Present or past synovitis | 37 (54) | ||
Patients with a vertebral fracture | 8 (12) | ||
mSASSS | 8 (0, 72) | 19 ± 21 | |
BASMI, score | 3.0 (1.0, 7.2) | 3.2 ± 1.6 | |
BASDAI, score | 2.7 (0.2, 7.9) | 3.1 ± 2.0 | |
ASDAS, score | 2.1 (1.0, 4.4) | 2.3 ± 0.9 | |
BAS-G | 2.2 (0, 9.8) | 3.0 ± 2.7 | |
BASFI, score | 2.0 (0, 8.7) | 2.6 ± 2.2 | |
ESR, mm/h | 10 (2, 73) | 14 ± 12 | |
CRP, mg/L | 5 (3, 71) | 9 ± 12 | |
HLA-B27 positive | 65 (94) | ||
Patients taking NSAID | 52 (75) | ||
Patients taking glucocorticoid | 1 (1) | ||
Patients taking DMARD | 21 (30) | ||
Methotrexate | 13 (19) | ||
Sulfasalazine | 5 (7) | ||
TNF inhibitors | 15 (22) |